4 ms·
> I don't see a way out of this without regulation, and I don't see that happening when the pharmaceutical industry has been so effective at influencing federal
by ef4 11y ago
> I don't see a way out of this without regulation, and I don't see that happening when the pharmaceutical industry has been so effective at influencing federal laws.
For many of these generic drugs, this is a case where markets have literally already solved the problem. They're available from European and Indian manufacturers at extremely low cost.
All we need to do is lower the trade barriers.
Remember, these are drugs that are already FDA approved. But the manufacturers can't sell in the US because the ANDA approval process is too onerous.
- jbapple 11y ago> For many of these generic drugs, this is a case where markets have literally already solved the problem. They're available from European and Indian manufacturers at extremely low cost. This fixes part of the problem, perhaps. But the article explains that it can take other manufacturers years to ramp up production if they aren't already making the drug. This also doesn't fix the problem for non-generics.